130 related articles for article (PubMed ID: 26779626)
1. Cyfip1 is downregulated in acute lymphoblastic leukemia and may be a potential biomarker in acute lymphoblastic leukemia.
Chen X; Qin L; Li P; Mo W
Tumour Biol; 2016 Jul; 37(7):9285-8. PubMed ID: 26779626
[TBL] [Abstract][Full Text] [Related]
2. Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.
Shi X; Chen X; Li WC; Mo LJ; Lin ZY; Li YY; Yang Z; Mo WN
Neoplasma; 2018; 65(2):292-295. PubMed ID: 29534591
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia.
Peng HX; Liu XD; Luo ZY; Zhang XH; Luo XQ; Chen X; Jiang H; Xu L
BMC Cancer; 2017 Jan; 17(1):76. PubMed ID: 28122538
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.
He YZ; Liang Z; Wu MR; Wen Q; Deng L; Song CY; Wu BY; Tu SF; Huang R; Li YH
Leuk Res; 2015 Jun; 39(6):575-81. PubMed ID: 25843487
[TBL] [Abstract][Full Text] [Related]
7. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
8. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin 15 in primary adult acute lymphoblastic leukemia.
Wu S; Fischer L; Gökbuget N; Schwartz S; Burmeister T; Notter M; Hoelzer D; Fuchs H; Blau IW; Hofmann WK; Thiel E
Cancer; 2010 Jan; 116(2):387-92. PubMed ID: 19924795
[TBL] [Abstract][Full Text] [Related]
10. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
11. Telomerase (
Nogueira BMD; da Costa Pantoja L; da Silva EL; Mello Júnior FAR; Teixeira EB; Wanderley AV; da Silva Maués JH; de Moraes Filho MO; de Moraes MEA; Montenegro RC; Khayat AS; Moreira-Nunes CA
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681025
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
[TBL] [Abstract][Full Text] [Related]
13. Construction of three-gene-based prognostic signature and analysis of immune cells infiltration in children and young adults with B-acute lymphoblastic leukemia.
Xiang C; Wu J; Yu L
Mol Genet Genomic Med; 2022 Jul; 10(7):e1964. PubMed ID: 35603962
[TBL] [Abstract][Full Text] [Related]
14. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
[TBL] [Abstract][Full Text] [Related]
15. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract][Full Text] [Related]
16. PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia.
Oliveira JC; Pezuk JA; Brassesco MS; Morales AG; Queiroz RG; Scrideli CA; Tone LG
Pediatr Blood Cancer; 2014 Jul; 61(7):1227-31. PubMed ID: 24519995
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
Chang JW; Kuo WH; Lin CM; Chen WL; Chan SH; Chiu MF; Chang IS; Jiang SS; Tsai FY; Chen CH; Huang PH; Chang KJ; Lin KT; Lin SC; Wang MY; Uen YH; Tu CW; Hou MF; Tsai SF; Shen CY; Tung SL; Wang LH
Oncogene; 2018 Jul; 37(30):4137-4150. PubMed ID: 29706651
[TBL] [Abstract][Full Text] [Related]
18. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
